• 1
    Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997; 157: 12540.
  • 2
    Riddell SR, Berger C, Murata M et al . The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation. Blood Rev 2003; 17: 15362.
  • 3
    Kolb HJ, Mittermuller J, Clemm C et al . Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 24625.
  • 4
    Burroughs L, Storb R. Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease. Curr Opin Hematol 2005; 12: 4554.
  • 5
    Childs R, Chernoff A, Contentin N et al . Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 7508.
  • 6
    Tykodi SS, Warren EH, Thompson JA et al . Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clin Cancer Res 2004; 10: 7799811.
  • 7
    Meunier MC, Delisle JS, Bergeron J et al . T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med 2005; 11: 12229.
  • 8
    Fontaine P, Roy-Proulx G, Knafo L et al . Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med 2001; 7: 78994.
  • 9
    Chen BJ, Cui X, Sempowski GD et al . Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 2004; 103: 153441.
  • 10
    Dickinson AM, Wang XN, Sviland L et al . In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 2002; 8: 41014.
  • 11
    Den Haan JM, Meadows LM, Wang W et al . The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998; 279: 10547.
  • 12
    Klein CA, Wilke M, Pool J et al . The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J Exp Med 2002; 196: 35968.
  • 13
    Miyazaki M, Akatsuka Y, Nishida T et al . Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells. Clin Immunol 2003; 107: 198201.
  • 14
    Goulmy E, Schipper R, Pool J et al . Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 2815.
  • 15
    Mutis T, Verdijk R, Schrama E et al . Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93: 233641.
  • 16
    Hambach L, Nijmeijer BA, Aghai Z et al . Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice. Leukemia 2006; 20: 3714.
  • 17
    De Rijke B, Van Horssen-Zoetbrood A, Beekman JM et al . A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest 2005; 115: 350616.
  • 18
    Brickner AG, Evans AM, Mito JK et al . The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 2006; 107: 377986.
  • 19
    Kawase T, Akatsuka Y, Torikai H et al . Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 2007 Apr 4; [Epub ahead of print].
  • 20
    Marijt WA, Heemskerk MH, Kloosterboer FM et al . Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 27427.
  • 21
    Nishida T, Akatsuka Y, Morishima Y et al . Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant. Br J Haematol 2004; 124: 62935.
  • 22
    Spierings E, Brickner AG, Caldwell JA et al . The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 2003; 102: 6219.
  • 23
    Warren EH, Vigneron NJ, Gavin MA et al . An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 2006; 313: 14447.
  • 24
    Brickner AG, Warren EH, Caldwell JA et al . The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001; 193: 195206.
  • 25
    Pierce RA, Field ED, Mutis T et al . The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 2001; 167: 322330.
  • 26
    Den Haan JM, Sherman NE, Blokland E et al . Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995; 268: 147680.
  • 27
    Torikai H, Akatsuka Y, Miyazaki M et al . The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303. Br J Haematol 2006; 134: 40616.
  • 28
    Dolstra H, De Rijke B, Fredrix H et al . Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. Eur J Immunol 2002; 32: 274858.
  • 29
    Dolstra H, Fredrix H, Maas F et al . A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 1999; 189: 3018.
  • 30
    Akatsuka Y, Nishida T, Kondo E et al . Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 2003; 197: 1489500.
  • 31
    Slager EH, Honders MW, Van Der Meijden ED et al . Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer. Blood 2006; 107: 495460.
  • 32
    Mommaas B, Kamp J, Drijfhout JW et al . Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. J Immunol 2002; 169: 31316.
  • 33
    Murata M, Warren EH, Riddell SR. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 2003; 197: 127989.
  • 34
    Maruya E, Saji H, Seki S et al . Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998; 92: 216976.
  • 35
    Yazaki M, Takahashi T, Andho M et al . A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes. Bone Marrow Transplant 1999; 24: 12937.
  • 36
    Torikai H, Akatsuka Y, Miyauchi H et al . The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206. Bone Marrow Transplant (in press).
  • 37
    Itoh Y, Mizuki N, Shimada T et al . High-throughput DNA typing of HLA-A-B-C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005; 57: 71729.
  • 38
    Akatsuka Y, Kondo E, Taji H et al . Targeted cloning of cytotoxic T cells specific for minor histocompatibility antigens restricted by HLA class I molecules of interest. Transplantation 2002; 74: 177380.
  • 39
    Akatsuka Y, Goldberg TA, Kondo E et al . Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 2002; 59: 50211.
  • 40
    Kloosterboer FM, Van Luxemburg-Heijs SA, Van Soest RA et al . Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. Leukemia 2004; 18: 798808.
  • 41
    Gubarev MI, Jenkin JC, Leppert MF et al . Localization to chromosome 22 of a gene encoding a human minor histocompatibility antigen. J Immunol 1996; 157: 544854.
  • 42
    Wang CY, Guttridge DC, Mayo MW et al . NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999; 19: 59239.
  • 43
    Kloosterboer FM, Van Luxemburg-Heijs SA, Van Soest RA et al . Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia. Blood 2005; 106: 39557.
  • 44
    Akatsuka Y, Torikai H, Inamoto Y et al . Bone marrow may be a reservoir of long-lived memory T cells specific for minor histocompatibility antigen. Br J Haematol 2006; 135: 41314.
  • 45
    Van Bergen C, Kester M, Jedema I et al . Multiple myeloma reactive T cells recognize an activation induced minor histocompatibility antigen encoded by the ATP dependent interferon responsive (ADIR) gene. Blood 2007; 109: 408996.
  • 46
    The International HapMap Project. Nature 2003; 426: 78996.
  • 47
    Ito M, Hiramatsu H, Kobayashi K et al . NOD/SCID/gamma (c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 317582.
  • 48
    Bonnet D, Warren EH, Greenberg PD et al . CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc Natl Acad Sci USA 1999; 96: 863944.
  • 49
    Kircher B, Wolf M, Stevanovic S et al . Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-versus-leukemia activity after donor lymphocyte infusion. J Immunother 2004; 27: 15660.
  • 50
    Warren EH, Kelley DM, Brown ML et al . Adoptive GVL therapy targeting minor histocompatibility antigens for the treatment of posttransplant leukemia relapse – update of the FHCRC experience. Blood 2002; 100: 633a.
  • 51
    Walter EA, Greenberg PD, Gilbert MJ et al . Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 103844.
  • 52
    Van Der Bruggen P, Traversari C, Chomez P et al . A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 16437.
  • 53
    Slingluff CL Jr, Engelhard VH, Ferrone S. Peptide and dendritic cell vaccines. Clin Cancer Res 2006; 12: 2342S5S.
  • 54
    Rice J, Dunn S, Piper K et al . DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens. Cancer Res 2006; 66: 543642.
  • 55
    Spierings E, Goulmy E. Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest 2005; 115: 3397400.
  • 56
    Verdijk RM, Kloosterman A, Pool J et al . Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004; 103: 19614.
  • 57
    Spierings E, Drabbels J, Hendriks M et al . A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS ONE 2006; 1: e42.
  • 58
    Wang W, Meadows LR, Den Haan JM et al . Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269: 158890.
  • 59
    Pierce RA, Field ED, Den Haan JM et al . Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol 1999; 163: 63604.
  • 60
    Warren EH, Gavin MA, Simpson E et al . The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 2000; 164: 280714.
  • 61
    Vogt MH, Goulmy E, Kloosterboer FM et al . UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 2000; 96: 312632.
  • 62
    Vogt MH, Van Den Muijsenberg JW, Goulmy E et al . The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 2002; 99: 302732.
  • 63
    Zorn E, Miklos DB, Floyd BH et al . Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004; 199: 113342.
  • 64
    Spierings E, Vermeulen CJ, Vogt MH et al . Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 2003; 362: 61015.
  • 65
    Ivanov R, Aarts T, Hol S et al . Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response. Clin Cancer Res 2005; 11: 1694703.
  • 66
    Torikai H, Akatsuka Y, Miyazaki M et al . A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol 2004; 173: 704654.